Carboprost Tromethamine Injection, Solution
Product Images NDC 25021-477

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carboprost Tromethamine (NDC 25021-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Car16 0000 01)

Chemical structure of Carboprost Tromethamine depicted with molecular components and ionic groups, showing the detailed 2D arrangement of atoms in the active ingredient.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Car16 0000 02)

Carboprost Tromethamine Injection, USP 250 mcg per mL in a 1 mL single-dose vial label. The label indicates intramuscular use only and equates 250 mcg to carboprost. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, USA, made in India. Includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.